NKTR
Nektar Therapeutics·NASDAQ
--
--(--)
--
--(--)
NKTR Filings
Filing Date
Form Description
Form Type
2026-03-12
Nektar Therapeutics (NKTR) Q4 2025 Earnings Call Transcript
Earnings Call
2026-03-12 · Earnings Call
Nektar Therapeutics (NKTR) Q4 2025 Earnings Call Transcript
2026-03-12
Form 8-K - Current report
Key Events
2026-03-12 · Key Events
Form 8-K - Current report
2026-03-06
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-03-06 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-20
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-20 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-02-20
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-20 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-02-18
Form 144 - Report of proposed sale of securities
Ownership
2026-02-18 · Ownership
Form 144 - Report of proposed sale of securities
2026-02-18
Form 144 - Report of proposed sale of securities
Ownership
2026-02-18 · Ownership
Form 144 - Report of proposed sale of securities
2026-02-13
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-13 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-13
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-13 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-02-13
Form 8-K - Current report
Key Events
2026-02-13 · Key Events
Form 8-K - Current report
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
